Literature DB >> 6275073

beta-Receptor numbers and thermodynamics in denervation supersensitivity.

R Bannister, A W Boylston, I B Davies, C J Mathias, P S Sever, D Sudera.   

Abstract

1. Denervation supersensitivity to adrenergic agonists occurs after degeneration of the sympathetic nervous system in the disease called multiple system atrophy (MSA) or the Shy Drager Syndrome.2. Supersensitivity to the chronotropic effect of i.v. isoprenaline on the heart was demonstrated in eight subjects with sympathetic nervous system degeneration and MSA.3. There was an increased number of beta-receptors present in MSA as measured by [H(3)]dihydroalprenolol ([H(3)]DHA) binding to beta-receptors on lymphocytes isolated from venous blood taken from the MSA subjects compared with [H(3)]DHA binding to lymphocytes from seven normal subjects. There was no difference in the affinity of lymphocyte beta-receptors for [H(3)]DHA in MSA.4. [H(3)]DHA binding to lymphocytes from MSA subjects was decreased at lower temperatures but was unaffected by lower temperatures in lymphocytes from normal subjects.5. Equilibrium constants for [H(3)]DHA binding to normal and MSA lymphocytes were similar, indicating that the affinity of the beta-receptors was similar in both groups. The equilibrium constants were little affected by cooling from 37 to 4 degrees C suggesting that the heat of reaction (enthalpy) for [H(3)]DHA binding was low. The Gibbs free energy change on binding was negative and similar in quantity for both normal and MSA lymphocytes. There was a similar, large, increase in entropy on binding of [H(3)]DHA to both normal and MSA lymphocytes, showing that the binding reaction was entropy driven.6. If lymphocyte beta-receptors reflect the status of cardiac beta-receptors, increased numbers of cardiac beta-receptors may contribute to the denervation supersensitivity to isoprenaline in MSA with sympathetic degeneration.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6275073      PMCID: PMC1243844          DOI: 10.1113/jphysiol.1981.sp013914

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  22 in total

1.  beta-Adrenergic receptor involvement in 6-hydroxydopamine-induced supersensitivity in rat cerebral cortex.

Authors:  J R Sporn; T K Harden; B B Wolfe; P B Molinoff
Journal:  Science       Date:  1976-11-05       Impact factor: 47.728

2.  A sensitive radioenzymatic assay for norepinephrine in tissues and plasma.

Authors:  D P Henry; B J Starman; D G Johnson; R H Williams
Journal:  Life Sci       Date:  1975-02-01       Impact factor: 5.037

3.  Elevated beta-adrenergic receptor number after chronic propranolol treatment.

Authors:  G Glaubiger; R J Lefkowitz
Journal:  Biochem Biophys Res Commun       Date:  1977-09-23       Impact factor: 3.575

4.  Reduced beta-adrenergic receptor concentrations in ageing man.

Authors:  D D Schocken; G S Roth
Journal:  Nature       Date:  1977-06-30       Impact factor: 49.962

5.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

6.  Cardiovascular reflexes and biochemical responses in progressive autonomic failure.

Authors:  R Bannister; P Sever; M Gross
Journal:  Brain       Date:  1977-06       Impact factor: 13.501

7.  Evidence favouring the existence of a single adrenergic receptor.

Authors:  G Kunos; M Szentivanyi
Journal:  Nature       Date:  1968-03-16       Impact factor: 49.962

8.  Identification of beta-adrenergic receptors in human lymphocytes by (-) (3H) alprenolol binding.

Authors:  L T Williams; R Snyderman; R J Lefkowitz
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

9.  Structural and dynamical aspects of membrane immunochemistry using model membranes.

Authors:  P Brûlet; H M McConnell
Journal:  Biochemistry       Date:  1977-03-22       Impact factor: 3.162

10.  Immunogenicity of liposomal model membranes in mice: dependence on phospholipid composition.

Authors:  T Yasuda; G F Dancey; S C Kinsky
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

View more
  9 in total

1.  Up-regulation of beta-adrenoceptors on circulating mononuclear cells after reduction of central sympathetic outflow by clonidine in normal subjects.

Authors:  Y Zoukos; T Thomaides; D V Pavitt; J P Leonard; M L Cuzner; C J Mathias
Journal:  Clin Auton Res       Date:  1992-06       Impact factor: 4.435

2.  Treating postural hypotension.

Authors:  R D Watson
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-14

3.  Multiple system atrophy: using clinical pharmacology to reveal pathophysiology.

Authors:  Jens Jordan; Cyndya Shibao; Italo Biaggioni
Journal:  Clin Auton Res       Date:  2015-03-11       Impact factor: 4.435

4.  Differentiation of receptor subtypes by thermodynamic analysis: application to opioid delta receptors.

Authors:  K D Wild; F Porreca; H I Yamamura; R B Raffa
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

5.  The effect of propranolol on exercise induced tachycardia is determined by plasma concentration and the density of adrenergic receptors on leukocytes.

Authors:  K Tawara; E Steiner; C von Bahr
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

6.  Increased fat and skeletal muscle beta-adrenergic receptors but unaltered metabolic and hemodynamic sensitivity to epinephrine in vivo in experimental human thyrotoxicosis.

Authors:  S B Liggett; S D Shah; P E Cryer
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

7.  Altered adrenoceptor responsiveness during adrenaline infusion but not during mental stress: differences between receptor subtypes and tissues.

Authors:  P T Larsson; A Martinsson; G Olsson; P Hjemdahl
Journal:  Br J Clin Pharmacol       Date:  1989-12       Impact factor: 4.335

8.  Heightened Hippocampal β-Adrenergic Receptor Function Drives Synaptic Potentiation and Supports Learning and Memory in the TgF344-AD Rat Model during Prodromal Alzheimer's Disease.

Authors:  Anthoni M Goodman; Bethany M Langner; Nateka Jackson; Capri Alex; Lori L McMahon
Journal:  J Neurosci       Date:  2021-05-05       Impact factor: 6.167

Review 9.  Chronic hypotension.

Authors:  I B Davies
Journal:  J R Soc Med       Date:  1982-08       Impact factor: 18.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.